Board-certified in Endocrinology, Diabetes & Metabolic Diseases (and Internal Medicine) with broad expertise in clinical and basic R&D in Industry and Academia. Executive level achievements in Phase 2 - Phase 4 clinical development strategies and programs for novel drugs and devices. Expertise in worldwide product life cycle management, including clinical and outcomes research, competitive product strategies, and clinical aspects of medical affairs, pharmacovigilance and regulatory issues. Strong leadership in departmental and people management. Successful track record building a vigorous academic Diabetes and Endocrinology clinical research center and clinical practice, including an accredited Fellowship program. Directed highly productive Diabetes laboratories studying insulin signaling and adiponectin vascular physiology with longstanding support from NIH and ADA. Internationally recognized expert in Diabetes with more than 220 publications, reviews and textbook co-editorships.